Gilead shopping Letairis

[Anonymous]

Top financials firms are talking about Gilead looking to sell Letairis and get out of PAH

 

[Anonymous]

Total BS

 

[Anonymous]

No BS. Gilead doesn't like being in a market where they aren't number 1. With Maci, Rio and now oral Trep they will never hold onto there $500 million dollar Letairis. Gilead doesn't want to report positive HIV sales, incredible Sovaldi sales and a loss of $100 million in PAH. Wall Street will crucify them and the stock price.

 

[Anonymous]

No BS. Gilead doesn't like being in a market where they aren't number 1. With Maci, Rio and now oral Trep they will never hold onto there $500 million dollar Letairis. Gilead doesn't want to report positive HIV sales, incredible Sovaldi sales and a loss of $100 million in PAH. Wall Street will crucify them and the stock price.

Letairis does nothing to GILD shares, no one cares about PAH.

 

[Anonymous]

Do I hear Lilly at the door?

 

[Anonymous]

Your a complete moron who would buy Letairis!

 

[Anonymous]

Soo ... I am seriously getting my ass kicked by Maci right now. How's everyone else feeling?

 

[Anonymous]

After listening to our marketing department this week, we are in complete denial and a lot of trouble.

 

[Anonymous]

Gilead has it's head in the sand and does not want to admit they took maci lightly. They are kicking my ass too, and I did well last year!

 

[Anonymous]

Gilead has it's head in the sand and does not want to admit they took maci lightly. They are kicking my ass too, and I did well last year!

What?! Aren't you in SALES? Does the "company" have to tell you to do everything?

 

[Anonymous]

No! But apparently we need to tell you how to set goals. Only 9% of the country is hitting goal!

 

[Anonymous]

What?! Aren't you in SALES? Does the "company" have to tell you to do everything?

Hi Tim!

 

[Anonymous]

Tim who, my entire district isn't hitting goal so Tim is not alone dick!

 

[Anonymous]

No! But apparently we need to tell you how to set goals. Only 9% of the country is hitting goal!

Quit complaining, you all agreed on the goal, I saw all the heads nodding at the meeting when they asked "is this goal doable?" Then you all cheered and clapped and screamed loudly.

 

[Anonymous]

This is Eric. Whats up?

 

[Anonymous]

Fuck off! I look forward to seeing the other 12 new hires at Intermune.

 

[Anonymous]

Merck pays $1B to buy into Bayer's cardio future

May 6, 2014 | By Damian Garde
SHARE





TOOLS
Comment
Print
Contact Author
Reprint
Merck ($MRK) plans to use the proceeds of its planned $14.2 billion consumer business sale to Bayer to beef up its pipeline, and the in-transition pharma giant isn't wasting any time, signing a billion-dollar deal with its new partner in a move to get its hands on some new cardiovascular drugs.

Under the agreement, Merck will hand over $1 billion up front to split the rights to Bayer's stable of drugs that modulate soluble guanylate cyclase (sGC), an enzyme tied to the widening of blood vessels. That includes ex-U.S. rights to Adempas, Bayer's FDA-approved treatment for pulmonary arterial hypertension, and stateside rights to vericiguat, a Phase II sGC modulator under development for worsening heart failure. Merck is on the line for another $1.1 billion in milestone payments tied to collective sales of the whole franchise, Bayer said.

Merck also gets opt-in rights on the rest of Bayer's early-stage sGC drugs and has agreed to make its similar candidates available under the same terms. The two plan to share costs and profits on all co-developed treatments along the way.



Read more: Merck pays $1B to buy into Bayer's cardio future - FierceBiotech http://www.fiercebiotech.com/story/merck-pays-1b-buy-bayers-cardio-future/2014-05-06#ixzz31Xq8cRoQ
Subscribe at FierceBiotech